Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Early research (Phase 1)Study completedNCT00513474
What this trial is testing

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Massachusetts General Hospital 46
Early research (Phase 1)Looking for participantsNCT06233110
What this trial is testing

Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

Who this might be right for
Chronic Graft Versus Host Disease
Stefanie Sarantopoulos, MD, PhD. 30
Testing effectiveness (Phase 2)Ended earlyNCT04446182
What this trial is testing

Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD

Who this might be right for
Chronic Graft-versus-host-disease
University of Utah 3
Early research (Phase 1)Study completedNCT04987333
What this trial is testing

Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Who this might be right for
Inflammatory Diseases
Amgen 32
Not applicableAvailableNCT07210619
What this trial is testing

Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Who this might be right for
oGVHD
Regenerative Ocular Immunobiologics LLC
Testing effectiveness (Phase 2)Study completedNCT00822770
What this trial is testing

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 47
Not applicableStudy completedNCT01174277
What this trial is testing

Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.

Who this might be right for
Blood Stem Cell Transplant FailureGraft Versus Host Disease
University of Kansas Medical Center 23
Testing effectiveness (Phase 2)Ended earlyNCT00374257
What this trial is testing

UVB Phototherapy Treatment of Oral Chronic GVHD

Who this might be right for
Oral Chronic Graft-versus-host Disease
Brigham and Women's Hospital 11
Testing effectiveness (Phase 2)Looking for participantsNCT07116031
What this trial is testing

Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

Who this might be right for
Chronic Graft Versus Host Disease
Sanofi 37
Testing effectiveness (Phase 2)Study completedNCT00186628
What this trial is testing

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Who this might be right for
Leukemia, Mast-CellMantle-cell Lymphoma
Stanford University 36
Not applicableActive Not RecruitingNCT04479995
What this trial is testing

Multidisciplinary Intervention In Chronic GVHD

Who this might be right for
Stem Cell Transplant ComplicationsGraft Vs Host DiseaseCoping Skills+1 more
Massachusetts General Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00144430
What this trial is testing

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

Who this might be right for
Graft vs Host Disease
Ann & Robert H Lurie Children's Hospital of Chicago 60